News
Reslizumab: FDA panel recommends approval for adults, but not children
An FDA advisory committee voted to approve reslizumab, a Teva-sponsored drug treating severe asthma, for use in patients aged 18 years and older,...
The two post hoc analyses were funded by Teva Pharmaceuticals. Both investigators serve on advisory boards for Teva and multiple other pharmaceutical companies.